This study concerns the role of proteoglycans in nervous system development. Proteoglycans, proteins that bear distinctive polysaccharides known as glycosaminoglycans, are widely distributed on cell surfaces and in the extracellular matrix. Many studies suggest that proteoglycans play critical roles in development, and this is thought to reflect their involvement in cell-cell and cell-matrix interactions. In the developing nervous system in particular, there is evidence that proteoglycans are involved in a variety of cell behaviors. Moreover, a striking proportion of proteins believed to influence neural development interact specifically with glycosaminoglycans. To understand the specific roles of proteoglycans in neural development, their sites and mechanisms of action must be defined. Before this can be done, however, it will first be necessary to identify the proteoglycans that are present in the developing nervous system and obtain tools that can be used to manipulate their functions. The expression of proteoglycans will therefore be examined in rat brain at various developmental stages (from embryonic to adult) and in various brain regions. Proteoglycans with provocative patterns of developmental and regional expression will be identified and monoclonal antibodies that recognize them will be obtained. Immunohistochemical data on the location and timing of expression of such proteoglycans will be used to suggest developmental events in which they participate. This information will then be correlated with two functionally important membrane protein?) and binding to glycosaminoglycan-binding proteins (does the proteoglycan bind selectively to proteins thought to mediate developmental events occuring when and where the proteoglycan is expressed?). The information and reagents to be obtained through this work are needed in order that direct in vitro and in vivo tests of the roles of individual proteoglycans in nervous system development may be conducted. Such studies will provide insights into the molecular mechanisms of mammalian brain development and will be directly relevant to the pathogenesis and treatment of development abnormalities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS026862-03
Application #
3412962
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1990-04-01
Project End
1993-12-14
Budget Start
1992-04-01
Budget End
1993-12-14
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
Other Domestic Higher Education
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Potkin, Steven G; Macciardi, Fabio; Guffanti, Guia et al. (2010) Identifying gene regulatory networks in schizophrenia. Neuroimage 53:839-47
Jen, Yi-Huei Linda; Musacchio, Michele; Lander, Arthur D (2009) Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis. Neural Dev 4:33
Ding, Kan; Lopez-Burks, Martha; Sanchez-Duran, Jose Antonio et al. (2005) Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. J Cell Biol 171:729-38
Murray, Richard C; Navi, Daniel; Fesenko, John et al. (2003) Widespread defects in the primary olfactory pathway caused by loss of Mash1 function. J Neurosci 23:1769-80
Lander, Arthur D; Nie, Qing; Wan, Frederic Y M (2002) Do morphogen gradients arise by diffusion? Dev Cell 2:785-96
Matsuda, K; Maruyama, H; Guo, F et al. (2001) Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 61:5562-9
Chen, R L; Lander, A D (2001) Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J Biol Chem 276:7507-17
Emerling, D E; Lander, A D (2000) Using organotypic tissue slices as substrata for the culture of dissociated cells. Methods Mol Biol 139:245-56
Herndon, M E; Stipp, C S; Lander, A D (1999) Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding. Glycobiology 9:143-55
Kleeff, J; Ishiwata, T; Kumbasar, A et al. (1998) The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 102:1662-73

Showing the most recent 10 out of 30 publications